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Abstract
Mutations in the gene encoding DJ-1 are associated with autosomal recessive forms of Parkinson’s disease (PD). DJ-1 plays a role
in protection from oxidative stress, but how it functions as an Bupstream^ oxidative stress sensor and whether this relates to PD is
still unclear. Intriguingly, DJ-1 may act as an RNA binding protein associating with specific mRNA transcripts in the human brain.
Moreover, we previously reported that the yeast DJ-1 homolog Hsp31 localizes to stress granules (SGs) after glucose starvation,
suggesting a role for DJ-1 in RNA dynamics. Here, we report that DJ-1 interacts with several SG components in mammalian cells
and localizes to SGs, as well as P-bodies, upon induction of either osmotic or oxidative stress. By purifying the mRNA associated
with DJ-1 in mammalian cells, we detected several transcripts and found that subpopulations of these localize to SGs after stress,
suggesting that DJ-1 may target specific mRNAs to mRNP granules. Notably, we find that DJ-1 associates with SGs arising from
N-methyl-D-aspartate (NMDA) excitotoxicity in primary neurons and parkinsonism-inducing toxins in dopaminergic cell cultures.
Thus, our results indicate that DJ-1 is associated with cytoplasmic RNA granules arising during stress and neurodegeneration,
providing a possible link between DJ-1 and RNA dynamics which may be relevant for PD pathogenesis.
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Introduction
DJ-1 is encoded by PARK7, a gene associated with autosomal
recessive forms of Parkinson’s disease (PD). Since the original
study linking DJ-1 to PD [1], several DJ-1 mutations have
been associated with familial forms of PD, with both homo-
zygous and compound heterozygous mutations causing early
onset PD [2]. DJ-1 is a small conserved protein of 189
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residues implicated in a variety of cellular roles, including
response to oxidative stress, mitochondrial health, protein
chaperone activity, and regulation of autophagy [3, 4].
However, this plethora of DJ-1 functions makes it difficult
to discern the key molecular mechanisms that connect DJ-1
to PD pathogenesis. One hypothesis is that there might be one
as yet undiscovered overarching function that explains these
roles in the cell [5]. Importantly, DJ-1 was first identified as
part of an RNA-binding complex [6] and exhibits RNA-
binding activity in human dopaminergic neuroblastoma cells
and mouse brain [7]. More notably, the association of DJ-1
with specific mRNA transcripts has been demonstrated in hu-
man brain, alongside an alteration in their corresponding pro-
tein levels in PD brains [8]. We have recently made the obser-
vation that Hsp31, a yeast DJ-1 homolog, is localized to stress
granules (SGs) and P-bodies (PBs) after glucose starvation
and that its deletion influences formation of these cytoplasmic
mRNP granules [9].
SGs are cytoplasmic aggregates that represent the morpho-
logical consequence of an mRNA triage process triggered by
environmental stresses [10]. These structures are characterized
by the presence of the translationally silent 48S preinitiation
complex (mRNA transcripts, 40S ribosomal proteins, eIF3,
eIF4A, eIF4B, eIF4G and eIF4E, and PABP-1) and represent
the physical place within the cytoplasm of stressed cells where
the fate of mRNA transcripts is decided. PBs, on the other hand,
are RNA granules that mediate RNA degradation and dynami-
cally interact with SGs [11], exchanging several components
[12]. Interestingly, SGs co-localize with insoluble protein aggre-
gates in several neurodegenerative diseases such as Alzheimer’s
disease (AD), frontotemporal dementia and parkinsonism linked
to chromosome 17 (FTDP17), and amyotrophic lateral sclerosis
(ALS), suggesting shared mechanisms regarding RNA dynam-
ics among these disorders [13, 14]. In several of these cases,
mutations in RNA binding proteins increase their self-
assembly ability, resulting in SG formation even in the absence
of stress. Persistent SGs can also be the consequence of muta-
tions in proteins involved in SG clearance [15]. In both scenar-
ios, the accumulation of Bchronic^ SGs completely alters the
RNA machinery and may trigger neurodegeneration [14, 16].
Here, we investigated the potential association of DJ-1
with SGs and PBs in mammalian systems and assessed the
functional consequences of these interactions. Using mass
spectrometry and co-immunoprecipitation (coIP), we find
that SG components interact with DJ-1. We demonstrate
that DJ-1 localizes to SGs and PBs after hyperosmotic
shock and oxidative stress in HEK 293T and SH-SY5Y
cells. In addition, we detected DJ-1-specific interactions
with a subset of mRNAs that localize to SGs upon
hyperosmotic shock. Notably, we also observed that DJ-1
co-localizes with SGs arising from neurodegeneration in
primary cortical neurons and embryonic stem cell-derived
dopaminergic neuronal cultures.
Materials and Methods
Cell Culture, Transient Transfection, and Stress
Treatment
HEK 293Tcells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM), high glucose, supplemented with 10% fe-
tal bovine serum (FBS), 100 units/ml penicillin, and 100 μg/
ml streptomycin, at 37 °C in a 95% air/5% CO2 atmosphere.
SH-SY5Y cells were cultured in D-MEM/F12 (1:1)
GlutaMAX, supplemented with 10% FBS, 100 units/ml pen-
icillin, and 100 μg/ml streptomycin in a 95% air/5% CO2
atmosphere. Cells were plated on 10 cm Petri dishes (2 × 106
cells/well) for immunoprecipitation studies, on coverslips
(1.5 × 105 cells/well) pre-coated with 0.01% poly-L-lysine so-
lution for immunocytochemistry studies, or in 6-well plates
(1.5 × 105 cells/well) pre-coated with 0.01% poly-L-lysine so-
lution for Park7 siRNA experiments. Transfection was per-
formed 24 h after plating using the Effectene Transfection
Reagent kit (QIAGEN) using procedures supplied by the
manufacturer. D-Sorbitol (Sigma) was diluted in standard
growth medium to yield a 0.4 or a 0.2 M concentration. For
oxidative stress treatment, 24 h after transfection, cells were
exposed to 200 μM paraquat for 24 h or to 1 mM hydrogen
peroxide for 2 h. Cycloheximide (CHX; Sigma-Aldrich) was
used at 50 μg/ml for 30 min.
Immunoprecipitation
To identify interaction partners of GFP-tagged DJ-1, we used
the GFP-Trap technique, a high-quality GFP binding system
based on a single domain antibody against GFP derived from
Camelids. Cells were lysed 48 h after transfection. Each con-
fluent 10 cm cell culture dish was washed twice in ice-cold
phosphate buffer saline (PBS) and lysed on ice for 5 min in
400 μl lysis buffer (20 mM Tris HCl, pH 7.4, 150 mM NaCl,
1% (v/v) Triton X100 supplemented with Roche EDTA free
complete mini protease inhibitors and PhosSTOP phosphatase
inhibitors). Lysates were centrifuged at 14,000 rpm for 15 min
at 4 °C. Supernatants were collected andGFP-trap beads (20μl
per reaction, Chromotek) were used according to the manufac-
turer instructions to immunoprecipitate GFP-DJ-1. Lysates
from untransfected cells were used as negative controls. To
identify endogenous DJ-1 interacting proteins, Dynabeads
M-270 Epoxy were coated with a polyclonal goat anti-DJ-1
antibody (ab4150, Abcam) using the Dynabeads Antibody
Coupling Kit (Invitrogen). Typically, 5 μg of antibody were
used per 1 mg of Dynabeads M-270 Epoxy and 1.5 mg of Ab-
coupled beads was used per reaction. Cell lysis was performed
as described above and immunoaffinity purification was
achieved by mixing at 4 °C for 1 h 30 min. Magnetic beads
were then collected using a magnet and washed three times
with dilution buffer (lysis buffer with no Triton). The DJ-1
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protein complex was eluted from the beads for 10min at 75 °C
in 1× SDS sample buffer. DJ-1 (exogenous and endogenous)
complex was separated on a 10% SDS PAGE, stained with
Coomassie Blue stain compatible with mass spectrometry
(ProtoBlue safe, National Diagnostic), and sent for mass spec-
trometry analysis at the Cambridge Centre for Proteomics,
University of Cambridge, UK. For the validation of DJ-1 in-
teraction partners, the immunocomplex was analyzed by im-
munoblotting. In the case of RNase A treatment, the enzyme
was added to lysates to yield final concentrations of 1 mg/ml,
and lysates were left at room temperature for 25 min followed
by incubation with the beads as described above.
Mass Spectrometry Analysis
Each gel lane was cut into five equally sized bands and washed,
reduced in 2 mM DTT for 1 h at RT, alkylated in 10 mM
Iodoacetamide for 30 min at RT and digested in-gel with 2 μg
sequencing-grade porcine trypsin (Promega) overnight at
37 °C. Digests were concentrated using a speedvac and resus-
pended in 0.1% formic acid. All LC-MS/MS experiments were
performed using a Dionex Ultimate 3000 RSLC nanoUPLC
(Thermo Fisher Scientific Inc., Waltham, MA, USA) system
and a QExactive Orbitrap mass spectrometer (Thermo Fisher
Scientific Inc., Waltham, MA, USA). Separation of peptides
was performed by reverse-phase chromatography at a flow rate
of 300 nl/min and a Thermo Scientific reverse-phase nano
Easy-spray column (Thermo Scientific PepMap C18, 2 μm
particle size, 100 A pore size, 75 μm i.d. × 50 cm length).
Peptides were loaded onto a pre-column (Thermo Scientific
PepMap 100 C18, 5 μm particle size, 100 A pore size,
300 μm i.d. × 5 mm length) from the Ultimate 3000
autosampler with 0.1% formic acid for 3 min at a flow rate of
10 μl/min. After this period, the column valve was switched to
allow elution of peptides from the pre-column onto the analyt-
ical column. Solvent A was water + 0.1% formic acid and
solvent B was 80% acetonitrile, 20%water + 0.1% formic acid.
The linear gradient employed was 2–40% B over 30 min. The
LC eluant was sprayed into the mass spectrometer by means of
an Easy-spray source (Thermo Fisher Scientific Inc.). All m/z
values of eluting ions were measured in an Orbitrap mass ana-
lyzer, set at a resolution of 70,000. Data-dependent scans (Top
20) were employed to automatically isolate and generate frag-
ment ions by higher energy collisional dissociation (HCD) in
the quadrupole mass analyzer and measurement of the resulting
fragment ions was performed in the Orbitrap analyzer, set at a
resolution of 17,500. Peptide ions with charge states of 2+ and
above were selected for fragmentation. Post-run, the data was
processed using Protein Discoverer (version 1.4,
ThermoFisher). Briefly, all MS/MS data were converted to
mgf files and these files were then submitted to the Mascot
search algorithm (Matrix Science, London UK) and searched
against the Uniprot human database (UniProt_Human_Oct13
9606, 153,168 sequences; 54,677,058 residues) using a fixed
modification of carbamidomethyl (C) and a variable modifica-
tion of oxidation (M). The peptide mass tolerance was set to
10 ppm, the fragment ion mass tolerance to 0.1 Da, and the
maximum number of missed cleavages to 2. Peptide identifica-
tions were accepted if they could be established at greater than
95.0% probability. emPAI scores as calculated as part of the
MASCOT search algorithm (Matrix Science, London) was
used for semi-quantitative analysis.
Immunoblotting
Cells were washed twice with sterile PBS and then lysed on
ice for 10 min in lysis buffer [17]. Lysates were centrifuged at
13,000 rpm for 10 min at 4 °C. Supernatants were collected
and protein concentration was determined by the Bradford
method. Samples were stored at − 80 °C until used. Proteins
were separated on a 10% SDS polyacrylamide gel (10 μg of
total proteins per well) and transferred to a polyvinylidene
difluoride membrane. Membranes were incubated for 1 h in
TBST 5% dried milk to saturate all non-specific binding sites.
Incubation with primary antibodies was overnight at 4 °C,
using mouse anti-DJ-1 antibody (1:1000; sc-55572, Santa
Cruz Biotechnology), rabbit anti-β-tubulin (1:1000; #2128,
Cell Signaling Technology), rabbit anti-eIF4A3 (1:1000;
ab32485, Abcam), or goat anti-TIA1 (1:200; sc-1751, Santa
Cruz Biotechnology). Blots were developed using horseradish
peroxidase (HRP)-conjugated secondary antibodies (1:10000;
Vector Laboratories) and the ECL chemiluminescence system
(SuperSignal West Dura Extended Duration Substrate,
Thermo Scientific).
siRNA Knockdown of DJ-1
ON-TARGETplus human PARK7 (11315) siRNA,
SMARTpool (catalog no L-005984-00-0005) was purchased
from Dharmacon siRNA Technologies (GE Healthcare) and
dissolved in 1X siRNA Buffer to obtain a 20 μM stock stored
in aliquots at − 20 °C before use. ON-TARGETplus non-
targeting pool siRNA (catalog no D-001810-10-05) was used
as a negative control, siGLO Red (catalog no D-001630-02-
05) was used as transfection control, and ON-TARGETplus
GAPD Control Pool (catalog no D-001830-10-05) was used
as a positive control. HEK 293Tcells were transfected accord-
ing to the manufacturer’s specifications using DharmaFECT 1
Transfection Reagent and treated with sorbitol or lysed 72 h
after transfection.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde in PBS for 20min at
37 °C and then incubated in 1% bovine serum albumin (BSA)
in PBS 0.2% Triton for 30 min at room temperature. Primary
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antibodies were diluted 1:100 (anti-DJ-1, #5933, Cell
Signaling Technology), 1:100 (anti-DJ-1, sc-55572, Santa
Cruz Biotechnology), 1:500 (anti-DJ-1, NBP1-92715,
Novus Biologicals), 1:200 (anti-G3BP, #611126, BD trans-
duction Laboratories), 1:200 (anti-eIF3η (N-20), sc-16377,
Santa Cruz Biotechnology), 1:100 (anti-TIA1 (C-20), sc-
1751, Santa Cruz Biotechnology), 1:1000 (anti-p54-RCK,
A300-416, Bethyl Laboratories), 1:1000 (anti-p70 S6 kinase
α/Hedls, sc-8418 Santa Cruz Biotechnology), 1:500 (anti-Tau
5, Calbiochem #577801), 1:200 (anti-eIF4A3, ab32485,
Abcam) in blocking solution and incubated overnight at
4 °C. After washing in PBS, cells were incubated for 2 min
in 1:2000 Hoechst 33342 trihydrochloride, 10 mg/ml solution
(Invitrogen), in PBS. Secondary antibodies conjugated to
Alexa 488, Alexa 546, Alexa 594, Alexa 647 (Invitrogen)
were diluted 1:500 in PBS 0.2% Triton + 1% BSA and incu-
bated at room temperature for 1 h. Finally, cells were rinsed in
PBS, and coverslips were mounted in Mowiol.
Confocal Laser Scanner Microscopy Analysis
Confocal laser scanner microscopy analysis (CLSM) analysis
was performed using an Olympus FV1000 confocal laser
scanning microscope. Cells were imaged in sequential mode
using a 60X UPlanSAPO Olympus objective, and Kalman
filter of 4. The following settings were used for: Hoechst—
excitation 405 nm laser line, emission detected between 425
and 475 nm; Alexa 488—excitation 488 nm laser line, emis-
sion detected between 500 and 545 nm; Alexa 546—excita-
tion 559 nm laser line, emission 575–675 nm; Alexa 594—
excitation 559 nm laser line, emission 575–675; Alexa 647,
emission—excitation 635 nm laser line, emission 655–
755 nm. The number of SGs/PBs per cell and their average
size were counted using the Stress Granule Counter plug-in
(Ann Sablina, Lomonosov Moscow State University, Russia)
for ImageJ software (Schneider et al. 2012) with the following
parameters: number of smoothes: 10, number of smoothes
after subtraction: 2, threshold: 3000, Min part size: 2, Max
part size: 10, circularity: 0.2. Ten confocal z-slices taken in
ten separated fields were counted in each experiment. At least
350 cells were counted per condition for each independent
experiment. Cell nuclei were counted manually using the
Cell Counter plug-in for ImageJ. For co-localization studies,
the ImageJ co-localization plug-in written by Pierre
Bourdoncle was employed. Three independent experiments
were performed for all conditions.
Precipitation of DJ-1 RNA Complexes
Immunoprecipitation reactions were as described in [18].
HEK 293T cells were allowed to reach confluence in 15 cm
petri dishes (n = 4) and harvested in polysome lysis buffer
(PLB) (10 mM Hepes, pH 7.0, 100 mM KCl, 5 mM MgCl2,
0.5% NP-40, 1 mM DTT, 100 units/ml RNase OUT and pro-
tease inhibitors). Each plate yielded approximately 200 μl of
lysate, 100 μl of which was used in each DJ-1 and IgG control
IP. DJ-1 (Abcam, ab4150) or IgG isotype control (Abcam,
ab37373) antibodies were conjugated to Protein G
Dynabeads (Invitrogen) for 10 min at RT with rotation. The
conjugated beads were incubated with cell lysate in NET2
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM
MgCl2, 0.05% NP-40, 20 mM EDTA, 1 mM DTT,
100 units/ml RNase OUT) for 1 h at RT and then washed six
times with cold NT2 buffer.
QPCR Analysis of Transcripts
RNA was released from the protein-bead complex by treat-
ment with Proteinase K (beads were resuspended in NT-2
buffer supplemented with 1% SDS, 1.2 mg/ml Proteinase K)
and was purified using acid phenol-chloroform followed by
precipitation in 100% ethanol containing 0.27 M ammonium
acetate, 0.12 M lithium chloride, and 5 mg/ml glycogen
(Ambion) at − 80 °C for 16 h. Precipitated RNAwas pelleted
and washed with 80% ethanol before resuspension in RNase-
free H2O. Then, 40 ng of RNA from each sample was used to
synthesize cDNAwith the Sensiscript® Reverse Transcription
kit (QIAGEN) according to the manufacturer’s protocol.
Further, 1 μl of cDNAwas used per technical replicate in a
10 μl reaction QPCR reaction with Maxima SYBR Green
master mix (Thermo Scientific) and primers at a final concen-
tration of 330 nM. QPCR reactions were performed on a
LightCycler 480 system (Roche). Amplification specificity
was confirmed by melt curve analysis of QPCR products
and –RT controls were included for each sample. Crossing
points (Cp) were calculated using the second derivative meth-
od. The ratio of mRNA levels in DJ-1 to IgG control samples
was calculated using the qpcR package in R Studio [19]—
amplification efficiencies were calculated using non-linear re-
gression of sigmoidal curves and incorporated into the ratio
calculation. Statistical significance of relative expression
levels was tested using a pairwise-reallocation test based upon
that used by REST software [20], where Cp and efficiency
values were permutated within control and treatment groups.
Ratios were calculated for each permutation and compared to
ratios obtained from the original data. The proportion of ratios
higher or lower than that obtained from the original data was
used to generate the P value of the test.
mRNA In Situ Hybridization
Cells were plated on NuncLab-Tek II CC2 chamber slides
(ThermoFisher Scientific) and fixed with 10% NBF before
being processed for RNA ISH using the RNAscope
Technology, Multiplex fluorescent assay, Advanced Cell
Diagnostics, Hayward, CA, USA. RNAscope probes were
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designed and provided by Advanced Cell Diagnostics,
Hayward, CA, USA: Hs-GPX4 (NM_001039847.2, region
9-943), Hs-EIF4B (NM_001300821.1, region 472-1419),
Hs-EIF4EBP1 (NM_004095.3, region 20-863). Positive and
negative control probes were respectively Hs-PPIB
(NM_000942.4, region 139-989) and DapB (EF191515, re-
gion 414-862). All probes were designed as C1 target probes.
Staining steps were in accordance with RNAscope protocols
with onemodification: protease III was incubated for 5 min, as
10 min resulted in a weaker and less clear IF staining. AMP4-
AltA-FL was used for the fluorescent labeling (channel 1 in
green). For sorbitol-treated cells (1 h, 0.4 M sorbitol), immu-
nofluorescence was performed following RNA ISH: after the
last washes at the end of the RNAscope assay protocol, slides
were washed in PBS and incubated in 1% bovine serum albu-
min (BSA) in PBS 0.2% Triton for 30 min at room tempera-
ture. Primary antibodies concentration was increased by
100%, as the ISH involves proteolytic treatment which might
destroy the antigen of interest. Secondary antibodies were
conjugated to Alexa 594 (Invitrogen) for eIF3 and TIA1, or
Alexa 647 (Invitrogen) for G3BP and used as previously de-
scribed. The number of ISH positive dots per cell was counted
using the Stress Granule Counter plug-in as previously de-
scribed for ImageJ software [21]. Ten confocal z-slices taken
in ten separated fields were counted in each experiment and
about 100 cells were counted per condition for each indepen-
dent experiment. Cell nuclei were counted manually using the
Cell Counter plug-in for ImageJ. For co-localization studies,
the co-localization plug-in for ImageJ was used.
Cortical Neuronal Culture
Primary neuronal cultures were obtained from the cortex of 2-
day-old rat pups, incubated with 200 U of papain for 30min at
34 °C and after trypsin inhibitor treatment (T-9253, Sigma
Aldrich, St Louis, USA; 10 μg, 45 min at 34 °C) were me-
chanically dissociated. For immunocytochemistry, neurons
were plated at densities of 70,000 cell/dish on chamber slides
(80826, IBIDI, München, Germany) precoated with 25 μg/ml
poly-D-lysine (Sigma P6407). The plating medium consisted
of B27/Neurobasal-A supplemented with 0.5 mM glutamine,
100 U/ml penicillin, and 100 μg/ml streptomycin (all from
Invitrogen). Experiments were performed after 12 days in cul-
ture at which time neurons had formed synapses. Cortical
neurons were exposed to N-methyl-D-aspartate (NMDA)
100 μM for 5 or 24 h.
Lactate Dehydrogenase Assay
Twelve DIV primary cortical neurons were treated with
NMDA 100 μM for 5 or 24 h. At the end of the treatment,
the medium was collected and the release of lactate dehydro-
genase (LDH) in the medium was quantified to assess cell
viability using the Cytotoxic 96 non-radioactive cytotoxicity
assay kit (Promega, WI, USA).
Maintenance and Differentiation of mES Cells
The NesE-Lmx1a ES cell line was propagated on MEF cells
as described [22, 23]. The mES cells were differentiated fol-
lowing the 5-stage protocol [24] with some minor modifica-
tions. For the initiation of EB formation (stage 2), cells were
dissociated with TryplE Express (Gibco) and purified on
gelatinized tissue culture dishes for 45 min. Cells were subse-
quently plated on non-adherent bacterial dishes for 3 days in
EB medium containing FBS (10%; Gibco) to allow EB for-
mation taking place. EBs were subsequently plated on tissue
culture dishes and allowed to attach. After attachment, EB
medium was changed next day for DMEM/F12 (Gibco) me-
dium containing insulin (Gibco), apo-transferrin, sodium-sel-
enite, and fibronectin (all Sigma) (ITSF medium; stage 3).
After 6 days in ITSF medium, neural precursor cells were
further expanded and patterned by splitting the cells with
TryplE Express and plating them on poly-ornithine and lam-
inin (Sigma) coated 24-well plates containing N3 medium
plus 10 ng/ml bFGF (R&D), 100 ng/ml FGF8 (R&D), and
100 nMHedgehog agonist Hh-Ag1.3 (Curis Inc., USA) (stage
4). After 4 days, neuronal differentiation was initiated by re-
moval of the growth factors and the cells were subsequently
kept in N3medium containing ascorbic acid for 12 days (stage
5). At this stage, the neuronal cultures were treated with either
MPP+ (10 and 20 μM), rotenone (50 nM), or DMSO as con-
trol for 3, 6, and 12 h. Cell were fixed with 2% PFA for 20min
and analyzed by immunohistochemistry. The following anti-
bodies were used: 1:500 rabbit Nurr1 (E20; Santa Cruz
Biotechnology), 1:1000 mouse TH (Millipore), and 1:200
goat eIF3η (N-20, Santa Cruz Biotechnology).
Statistical Analysis
Most data were analyzed with Prism 5 (GraphPad), using one-
way ANOVA followed by post-hoc analysis with Tukey’s test.
For two independent samples, an unpaired T test was used.
Two-way ANOVAwas used for the analysis of CHX effect
on SG formation followed by post-hoc analysis with Tukey’s
test. P values of less than 0.05 were considered significant for
any set of data. In all experiments, results are expressed as
means ± SEM.
Results
DJ-1 Interacts with Stress Granule Components
To investigate the potential association of DJ-1 with SGs, we
sought to identify DJ-1 interacting proteins using proteomic
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analyses. HEK 293T cells were transfected with a construct
encoding a GFP tagged version of DJ-1 yielding expression
levels comparable to those of the endogenous protein [25],
and DJ-1 complexes were immunoprecipitated using the
GFP-Trap technique. In parallel, we also performed coIP of
proteins interacting with endogenous DJ-1. These experi-
ments were performed in both control conditions and after
oxidative stress induced by paraquat treatment (24 h,
200 μM). Purified proteins were then separated by SDS-
PAGE, stained with Coomassie and each gel lane excised into
equal-sized segments and in-gel digested with trypsin, before
analysis of the resulting extracted peptides via liquid chroma-
tography tandem-mass spectrometry (LC-MS/MS). Mass
spectrometry identified several putative DJ-1 interactors, in-
cluding SG-associated proteins (Table S1). Indeed, we found
that several universal SG markers are DJ-1 interactors in both
control and oxidative stress conditions (e.g., eIF4A3, a splic-
ing factor core component of the exon junction complex (EJC)
[26], and the 40S ribosomal proteins S25, S3, and S7). In
addition, we identified several hnRNPs as DJ-1 interactors
(hnRNPM, hnRNPA2/B1, hnRNPA1, hnRNPV, hnRNPH).
Intriguingly, certain hnRNPs are known to be localized within
stress granules [27–30].
Next, we assessed the relative abundance of proteins associ-
ated with DJ-1 by carrying out a semi-quantitative analysis cal-
culating an Exponentially Modified Protein Abundance Index
(emPAI) score for each protein [31]. This method calculates the
number of peptides generated per protein and uses the proportion
of these compared with the number of peptides which could be
theoretically generated per protein as a read out of abundance.
The highest emPAI scores were recorded for 40S S25 and
eIF4A3 associated with endogenous DJ-1 in control conditions
(emPAI score 1.04 and 1.39 respectively), with an increasing
trend in levels under oxidative stress observed for both endoge-
nous and overexpressed DJ-1. To further interrogate these data,
we performed coIP experiments and found that both eIF4A3 and
hnRNPM specifically interact with endogenous DJ-1 (Fig. S1A;
data not shown). To gain further insight into the association of
DJ-1 with SGs, we compared our mass spectrometry results to
the unfixed stress granule proteome recently published by Jain
et al. [32]. Notably, 33 (~ 24%) of the 139 SG proteins identified
in non-fixed cells were found to be DJ-1 interacting proteins in
our studies. These data indicate that DJ-1 is associated with SG-
related proteins in mammalian cells, suggesting a potential novel
role in RNA dynamics.
DJ-1 Localizes to Stress Granules and P-Bodies
upon Induction of Stress
We then investigated the subcellular localization of DJ-1 un-
der SG inducing conditions to assess if DJ-1 co-localizes with
SGs. Sorbitol treatment inducing hyperosmotic shock was
employed as a standard approach to promote formation of
SGs, as determined by labeling with three established markers
(G3BP, eIF3η, and TIA1). Sorbitol treatment (0.4 M) resulted
in the formation of large cytoplasmic inclusions detected with
G3BP (Fig. 1a), eIF3 (Fig. 1b), and TIA1 (Fig. 1c) antibodies,
as previously described [33]. Interestingly, sorbitol changed
the localization of DJ-1 from homogeneous nuclear and cyto-
plasmic distribution, in control conditions, tomore perinuclear
and Binclusion-like^ signals after sorbitol treatment. Although
there were fewer DJ-1 positive cytoplasmic inclusions than
labeled SGs, there was a clear overlap in the signals,
confirming the occurrence of DJ-1 in SGs, as shown in the
intensity profile data (Fig. 1a–c). This subcellular localization
pattern is in agreement with previous data that found a large
proportion of SG components also localized to the cytoplasm
during stress [34], as well as these RNA granules. By quanti-
fying DJ-1/TIA1 co-localization, we found that ~ 55% ofDJ-1
positive granules were also TIA1 positive after 1 h of treat-
ment with 0.4 M sorbitol.
We subsequently used coIP assays to determine whether
DJ-1 was physically associated with the SG markers used in
the ICC studies. We immunoprecipitated endogenous DJ-1
from HEK 293T cell lysates after sorbitol treatment and com-
pared the signal obtained to that from control beads. Neither
G3BP nor eIF3η physically interacted with DJ-1 (data not
shown). However, we found that DJ-1 specifically interacted
with the 15 kDa TIA1 isoform, which is strongly associated
with SGs, and not with the 40 kDa TIA1 isoform (Fig. S1B)
[35, 36]. It has recently been shown that the protein tau—
which plays a role in stabilizing microtubules and is linked
to the pathology of both AD and PD—localizes to SGs and
interacts with TIA1 [37, 38]. We thus analyzed tau and DJ-1
expression by ICC in SH-SY5Y cells after sorbitol treatment
and we found that tau and DJ-1 co-localize within SGs iden-
tified by eIF3η (Fig. 1d), further confirming the association of
these proteins to SGs, and highlighting a potentially novel
pathogenic link between them.
We next asked whether DJ-1 was associated with SGs
formed in response to other stimuli. We exposed HEK 293T
cells to hydrogen peroxide (H202; 1 mM for 2 h) and assessed
SG formation via both eIF3η and TIA1 immunolabeling. Both
eIF3η (Fig. 2a) and TIA1 (Fig. 2b) staining showed the pres-
ence of SGs in the cytoplasm, which were smaller in size and
fewer in number in comparison to those forming in response
to sorbitol. Double immunolabeling with anti-DJ-1 antibody
confirmed the presence of DJ-1 in both eIF3η and TIA1 pos-
itive SGs after H2O2 treatment (Fig. 2a, b). These data suggest
that the association of DJ-1 with SGs is a general feature of
stress response in HEK 293T cells and is not stimulus
dependent.
SGs are dynamic cytoplasmic structures containing aggre-
gates of mRNA bound to 48S preinitiation factors and RNA
binding proteins involved in different aspects of RNA trans-
lation or metabolism, as well as proteins that play roles in
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cellular pathways not directly related to RNA metabolism
[39]. Above, we identified two proteins which physically in-
teract with DJ-1 and are known to associate with RNA:
eIF4A3 and TIA1, suggesting that these interactions may be
mediated by a mutual association with the same mRNA tran-
script. To investigate this question, we performed coIP assays
in the presence or absence of RNase A (Fig. 3) and found that
DJ-1 association with eIF4A3 is likely mediated by the bind-
ing of both proteins to the same transcripts, as it completely
disappears upon RNase treatment (Fig. 3a). Conversely, the
interaction of DJ-1 with the 15 kDa TIA1 isoform is not ab-
rogated upon RNase treatment (Fig. 3b), suggesting that
protein-protein interactions between TIA1 and DJ-1 occur in
the absence of RNA.
As we previously found that the yeast DJ-1 family member
Hsp31 is associated with both SG and PBs—and as the interac-
tion between these structures is highly dynamic—we next ex-
plored whether DJ-1 was a component of PBs arising from
hyperosmotic shock induced by sorbitol. We employed two
PB markers to test for co-localization: p54/RCK and Hedls.
Fig. 1 DJ-1 localizes to stress
granules after hyperosmotic
stress. Confocal images of
untreated HEK 293T cells (top
row in each panel) compared to
cells treated with 0.4 M sorbitol
for 2 h (a, b) or 1 h (c) (bottom
row in each panel). DJ-1 changes
its cellular distribution becoming
more dotted and perinuclear after
sorbitol treatment. Double
immunostaining for DJ-1 and
G3BP (a), DJ-1 and eIF3η (b),
and DJ-1 and TIA1 (c) clearly
shows DJ-1 co-localization with
some stress granules, as indicated
in the intensity profile data (the y-
axis represents fluorescence
intensity, the x-axis represents the
length of the line drawn in the
picture above). Images are
representative of at least N = 3
experiments. Scale bar = 5 μm.
Triple immunostaining for eIF3η,
tau, and DJ-1 in SH-SY5Y cells
shows DJ-1 and tau colocalization
within SGs after sorbitol
treatment (d). Scale bar = 5 μm
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As expected, PBs were observed in unstressed cells which in-
creased in both number and size after sorbitol treatment (Fig. 4).
No co-localization between DJ-1 and p54 or Hedls was ob-
served in control conditions; however, after hyperosmotic
shock, the subcellular localization of DJ-1 changedwith a subset
co-localizing with p54-labeled PBs (Fig. 4a). DJ-1 and Hedls
co-localization in PBs was rarely observed; however, clear over-
lap of the two fluorescent signals was present in perinuclear
regions after sorbitol treatment (Fig. 4b).
DJ-1 Behaves as a Bona fide SG Component
The RNA and protein components of SGs are highly dynamic
and in equilibrium with polysomes [39, 40]. Indeed, it is pos-
sible to trap SG components into polysomes by inhibiting
translation elongation [41, 42]. Thus, to further confirm that
DJ-1 is behaving as a bona fide SG protein, we next explored
the effect of cycloheximide (CHX) on stress granule formation.
HEK 293T cells were treated with either 0.2 or 0.4 M sorbitol
for 30min before CHXwas added to the culture medium for an
additional 30 min. Cells were then fixed, labeled with anti-
G3BP, anti-TIA1, and anti-DJ-1 antibodies, and the number
and size of SG were evaluated as described above (Fig. 5a).
Our results strongly support the notion that the DJ-1 associated
structures are true SGs, as the CHX effect we observed was a
function of sorbitol concentration. Indeed, no CHX effect was
detected at 0.4 M for G3BP positive stress granules, while a
strong reduction of G3BP positive granules/cell and size was
present when cells were treated with 0.2 M sorbitol. This indi-
cates that 0.4 M sorbitol completely blocks translation initia-
tion thereby preventing the CHX treatment effect, which was
readily detected with 0.2 M sorbitol, when residual translation
was likely still occurring. A similar response to CHX treatment
was observed when we used TIA1 as a SGmarker, although in
this case, there was more of an effect on granule size than on
the number of granules per cell. Interestingly, the behavior of
DJ-1 positive granules mirrored what we observed with TIA1
positive granules. These data indicate that DJ-1 can likely shift
from polysomes to SG as a function of sorbitol concentration,
as well as further underscoring that DJ-1 and TIA1 are highly
associated within SGs.
DJ-1 Plays a Role in SG Dynamics
The above evidence of DJ-1 association with SGs and PBs
prompted us to explore the nature of this involvement. First,
Fig. 2 DJ-1 localizes to stress
granules after oxidative stress.
Confocal images of untreated
HEK 293T cells (top row in each
panel) compared to cells treated
with 1 mM hydrogen peroxide for
2 h (bottom row in each panel).
Double immunostaining for DJ-1
and eIF3η (a) and DJ-1 and TIA1
(b), shows that DJ-1 co-localizes
with some stress granules after
oxidative stress. Scale bar = 5 μm
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we tested whether DJ-1 could play a role in determining the
size or number of SGs/PBs. We employed RNAi to knock-
down PARK7, which abrogated DJ-1 protein expression 72 h
after transfection (Fig. S2G), and subsequently scored SG
number and size. Seventy-two hours after transfection, cells
were treated with 0.4 M sorbitol for either 2 h (Fig. S2A) or
30 min (Fig. S2B), fixed and labeled with an anti-G3BP (Fig.
S2A) or an anti-eIF3η antibody (Fig. S2B). Knockdown of
DJ-1 did not have any effect on the number or size of SGs
evaluated using these two different markers. As 0.4M sorbitol
provides a relatively strong hyperosmotic shock—and under
these conditions translation is likely to be completely
blocked—we repeated the experiment in milder conditions
using 0.2 M sorbitol for 1 h and we labeled SG with eIF3η
(Fig. S2C) or TIA1 antibody (Fig. S2D). Again, no effect of
DJ-1 silencing was observed compared to control cells. We
further analyzed the number and size of PBs upon DJ-1
knockdown both in control conditions (Fig. S2E) and after
1 h 0.4 M sorbitol treatment (Fig. S2F) using p54 and Hedls
as markers. As with the SGs, we did not detect any significant
changes upon depletion. Thus, unlike our observations in
yeast, we find that although DJ-1 is localized to SGs and
PBs upon stress induction, it is not involved in formation of
these structures at a gross level.
We next asked whether DJ-1 plays a role in mRNA dynam-
ics within SGs, as mRNAs are core components of SGs/PBs
and DJ-1 has been shown to associate with specific mRNA
targets in vitro and in vivo [7, 8]. First we verified by RT-PCR
the expression of several previously identified DJ-1-
associated transcripts in HEK 293T cells (data not shown)
and focused our attention on the GPx4, eIF4B, and
eIF4EBP1 mRNAs due to their relevant cellular roles. The
glutathione GPx4 is a key antioxidant protein, while
eIF4B protein is a SG component [10] and eIF4EBP-1 reg-
ulates the SG localization of eIF4E [43]. DJ-1-mRNA com-
plexes were immunoprecipitated from HEK 293T cell ly-
sates and associated mRNAs were isolated and detected
by QPCR. We found that the GPX4, eIF4B, and eIF4EBP1
transcripts were significantly enriched in the DJ-1-
immunoprecipitated samples as compared to IgG controls
(Fig. 5b), confirming the specificity of DJ-1 interaction with
these mRNAs in HEK 293T cells.
These data further stimulated us to investigate if the DJ-1
interacting transcripts localized to SGs induced by
hyperosmotic shock. RNA in situ hybridization (ISH) using
the RNAscope Multiplex Assay permitted visualization of
individual RNAs as single, small fluorescent dots [44] which
were analyzed in combination with immunofluorescence (IF)
for SG markers. Our data clearly show that this ISH approach
specifically detects the presence of the three candidate
mRNAs in HEK 293T cells (Fig. S3). We then used ISH to
detect each of the three transcripts in combination with IF with
SG markers (eIF3η and G3BP) after 1 h sorbitol treatment.
The combination of detecting the mRNAs in the green chan-
nel (488 nm) and SGs in the far-red channel (647 nm) provid-
ed good contrast (Fig. 6a) in agreement with previous results
[45]. Interestingly, we found that ~ 20% of GPX4 mRNA
signal co-localized with the two SG markers (Fig. 6b).
Similarly, ~ 25% of eIF4B and eIF4EBP1 co-localized to
these markers. Notably, only ~ 5% of the mRNA signals co-
localized to the PB control, indicating a significant enrichment
of these candidate mRNAs with SGs versus other RNA gran-
ules (e.g., PBs). These data suggest that a subset of mRNAs
may be targeted to SGs by DJ-1.
Fig. 3 Characterization of the
interaction between DJ-1 and
associated proteins. The
interaction between DJ-1 and
eIF4A3 is likely mediated by the
binding of both proteins to the
same mRNA transcripts, as it
clearly disappears after RNAse A
treatment (a).
DJ-1 interaction with the 15 kDa
TIA1 protein does not change
after RNA depletion (b). Images
are representative of at least N = 3
experiments
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DJ-1 Is Associated with SGs in Neuronal Models
of Cellular Toxicity
We also considered the role of DJ-1 and SGs in cellular tox-
icity models relevant for neurodegenerative disease. In this
regard, we first employed a primary rat neuronal model of
excitotoxicity. In the CNS, excessive N-methyl-D-aspartate
(NMDA) receptor activation leads to excitotoxicity, an impor-
tant mechanism involved in cell death in many acute and
degenerative neurological disorders [46]. In PD, in particular,
the loss of dopaminergic neurons in the substantia nigra pars
compacta results in an excessive glutamatergic input into sev-
eral areas of the basal ganglia [47] and NMDA receptors pres-
ent on dopaminergic neurons are the targets for PD therapeutic
drugs [48, 49]. As we have previously extensively character-
ized a model of NMDA excitotoxicity in rat primary cortical
neurons (excitotoxicity induced at 12 DIV by treatment with
100 μM NMDA [50, 51]), we employed this model to ascer-
tain whether this treatment induces SGs in primary neurons,
which is likely relevant to other neuronal types, including
dopaminergic neurons. We first looked for the presence of
SGs in NMDA-treated neurons versus control cells. Notably,
we found that NMDA receptor overactivation induces forma-
tion of SGs in primary cortical neurons, as indicated by both
eIF3η and TIA1 labeling (Fig. 7b, data not shown), indicating
that excitotoxicity causes a reorganization of the RNA ma-
chinery in neuronal cells. Indeed, while in control conditions
eIF3η signal is mainly cytoplasmic, after 5 h NMDA treat-
ment, it becomes punctate and spreads into the neuropil, with
this change in protein localization being even more evident
after 24-h treatment (Fig. 7b). Similar results were obtained
using TIA1 as a SG marker (data not shown). We investigated
DJ-1 in this model and found that after 24 h of NMDA treat-
ment, DJ-1 changes its cellular localization in a similar way to
that observed for eIF3η, with a fluorescent signal predomi-
nantly localized to axons and dendrites and to the perinuclear
region (Fig. 7c), where we observed co-localization with the
eIF3η signal.
Finally, we considered whether mitochondrial toxins caus-
ing the selective degeneration of substantia nigra dopaminer-
gic neurons in PD could induce SGs associated with DJ-1. We
derived homogeneous cultures of dopaminergic neurons from
mouse ES cells expressing Lmx1a under control of the Nestin
enhancer (NesE-Lmx1a) [22, 23] and treated these cultures
Fig. 4 DJ-1 localizes to P-bodies
after hyperosmotic stress.
Confocal images of untreated
HEK 293T cells (top row in each
panel) compared to cells treated
with 0.4 M sorbitol for 2 h
(bottom row in each panel). P-
bodies were detected in both un-
treated and treated conditions.
Double immunostaining for DJ-1
and p54/RCK (a) shows that DJ-1
co-localizes with some P-bodies
after hyperosmotic shock. Double
immunostaining for DJ-1 and
GE1/Hedls (b) clearly indicates
co-localization of the two proteins
in the perinuclear region. Scale
bar = 5 μm
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with either 20 μM MPP+ or 50 nM rotenone for 3, 6, 12, or
24 h. The presence of SGs was evaluated using immunofluo-
rescence with eIF3η signal as a marker for these RNA gran-
ules. Strikingly, we observed that both of these mitochondrial
toxins induced formation of SGs at the early time points of 3
and 6 h (Fig. 8a), while at the later time points of 12 and 24 h,
these RNA granules were no longer visible (data not shown).
In control cultures, SG formation was never observed.
Labeling of these neuronal cultures with the dopaminergic
neuronal marker Nurr1 after these toxic insults found that
SGs were only present in cells with diminished expression
of this marker, while neurons that did not show SG formation
Fig. 5 DJ-1 behaves as a bona fide stress granule component and
interacts with specific mRNAs. a Sensitivity of stress granules to
cycloheximide. HEK 293T cells were treated with 0.2 or 0.4 M sorbitol
for 30 min and then incubated with cycloheximide for another 30 min in
the presence of sorbitol. Cells were fixed and stained with anti-G3BP,
anti-TIA1, and anti-DJ-1 antibodies. Cycloheximide causes a reduction in
the number and size of G3BP positive stress granules size and a reduction
in size of TIA1 positive stress granules as a function of sorbitol concen-
tration. DJ-1 labeling shows a similar reduction after cycloheximide treat-
ment with behaviour comparable to TIA1. ~ 600 cells were counted for
each condition from two independent experiments. Data are shown as
mean ± SEM. Statistical analysis by two-way ANOVA followed by post
hoc analysis with a Tukey’s test; *P < 0.05; **P < 0.01; ***P < 0.001;
**** P < 0.0001. b DJ-1 interacts with specific mRNAs in HEK 293T
cells. Cells were lysed and anti-DJ-1 and non-specific IgG antibodies
were used to immunoprecipitate RNA bound to DJ-1 or background,
respectively. The amount of transcripts associated with each sample
was measured by QPCR, and levels of β-actin mRNA were used as
a non-specific control. By normalizing to β-actin mRNA levels in
each sample, an enrichment of the three transcripts was observed in
DJ-1 IP samples compared to IgG IP samples (increase of ~ 16-fold,
~ 2.4-fold, and ~ 6.1-fold, respectively, for GPx4, eIF4B, and
eIF4EBP1). Statistical significance was determined by comparing
DJ-1 to IgG IP; ***P < 0.001
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expressed normal levels of Nurr1 (Fig. 8a). Notably, while the
majority of cells (~ 70%) in culture were tyrosine hydroxylase
(TH)-positive, as expected, SG-containing cells never showed
TH signal (Fig. S4). Double immunolabeling for DJ-1 and
eIF3η indicated that DJ-1 co-localized to the SGs resulting
from MPP+ and rotenone (Fig. 8b) treatment. In total, these
data suggest that alterations in the RNA machinery may arise
in models of neuronal toxicity, and that DJ-1 may play a role
in this process.
Discussion
Here, we present novel observations that DJ-1 is associated
with mRNP granules, suggesting a potential role for DJ-1 in
modulation of the RNA machinery which may be important
for its pathogenic role in PD and other neurodegenerative
disorders. Specifically, we identified several SG components
and related proteins (eIF4A3, hnRNP family proteins, and 40S
ribosomal proteins) as DJ-1 interacting proteins by mass spec-
trometry, with subsequent coIP experiments validating
eIF4A3 and hnRNPM as DJ-1 interactors. eIF4A3 is a mem-
ber of the eIF4A family of DEAD-box RNA helicases, three
of which have been described in vertebrates (eIF4A1, eIF4A2,
eIF4A3). eIF4A3 is a core component of the exon junction
complex (EJC) [26], resides in the nucleus, and may serve as
an RNA clamp escorting spliced mRNAs from the nucleus to
various cellular compartments [52], while eIF4A1 and
eIF4A2 are cytoplasmic proteins whose helicase activity is
stimulated by their binding partners eIF4G and eIF4H.
Notably, eIF4A family members are core components of
SGs [10, 53] and eIF4A3 has recently been described as a
Fig. 6 DJ-1 interacting mRNAs
localize to stress granules upon
induction of stress. a Double
RNAscope in situ hybridization
and eIF3η
immunohistochemistry. The
merged picture shows co-
localization of a subpopulation of
mRNAs to eIF3 positive granules.
Scale bar = 5 μm. b An
enrichment of RNA dots
representing GPX4, eIF4B, and
eIF4EBP1 RNA messages
localized to stress granule
markers (eIF3η and G3BP) was
observed in comparison to a P-
body marker (p54)
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Fig. 7 NMDA excitotoxicity
induces DJ-1 positive stress
granules in primary cortical
neurons. a Neuronal death
assayed by LDH release after 5
and 24 h NMDA exposure.
Quantifications were performed
in at least four independent
experiments. Data are shown as
mean ± SEM. b Confocal images
of primary cortical neurons
untreated (left panels) compared
to neurons treated with NMDA
for 5 or 24 h (right panels). eIF3η
immunolabeling indicates that
NMDA induces stress granules at
both 5 and 24 h treatment. Scale bar
= 10 μm. c Cortical neurons were
treated with NMDA for 24 h,
fixed and double immunolabeled
for eIF3η and DJ-1. DJ-1 changes
its cellular distribution becoming
more dotted and distributed in the
neuropil after 24 h NMDA
treatment. Scale bar = 10 μm. d
Higher magnification images
show co-localization of the two
proteins mainly in the perinuclear
region. Scale bar = 5 μm. Images
are representative of at least N= 3
experiments
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member of the SG proteome [32]. We found that the interac-
tion between DJ-1 and eIF4A3 is likely dependent upon the
presence of mRNA transcripts associated with both proteins
and that upon sorbitol treatment DJ-1 and eIF4A3 strongly co-
localized to the perinuclear region (data not shown).
Therefore, it is possible that DJ-1 works in concert with
eIF4A3 to target spliced mRNAs from the nucleus to SGs in
the cytoplasm during stress. Remarkably, eIF4A3—as a com-
ponent of the EJC—is involved in the pioneer round of trans-
lation, which is critical for RNA quality control [54]. hnRNPs
are also RNA binding proteins that have been linked to several
aspects of RNAmetabolism (for a review see [55]). hnRNPA1
[27, 28], hnRNPA2 [29], and hnRNPK [30] have all been
described as SG components. Notably, Caenorhabditis
elegans SUP-46, an RNA binding protein with homology to
human hnRNPM, was found to localize to SGs after heat
stress [56]—further suggesting that hnRNPM may also be a
SG protein.
We also observed that DJ-1 strongly interacts with the
15 kDa SG-associated form of TIA1 comprising a C-
terminal region arising from proteolytic cleavage [57], a
well-described SG marker. Interestingly, this association is
RNA-independent, suggesting that DJ-1 interacts with TIA1
by a different mechanism than with eIF4A3. Furthermore,
upon SG induction by two different stimuli (osmotic shock
and oxidative stress), we clearly observed co-localization of
DJ-1 and SGs labeled with TIA1, G3BP, and eIF3 in HEK
293T cells, and co-localization of DJ-1 with TIA1 and tau in
Fig. 8 Parkinsonian neurotoxins
induce DJ-1 positive stress
granules in dopaminergic cell
cultures. a Confocal images of
control dopaminergic cultures and
dopaminergic cultures treated
with 20 μMMPP+ or 50 nM
rotenone for 6 h (upper panel =×
20 magnification, lower panel =×
40 magnification). Double
immunostaining for eIF3 and
NURR1 shows the presence of
SGs in in cells with a low level of
NURR1. (Scale bar = 10 μm). b
DJ-1 co-localizes to SGs arising
fromMPP+ or rotenone treatment
in dopaminergic cultures (6 h,
Rotenone 50 nM or MPP+
20 μM). Scale bar = 5 μm
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SH-SY5Y cells after sorbitol treatment (Fig. S5, Fig. 1d). To
further confirm a biological role of DJ-1 in SGs, during stress
conditions we observed partial co-localization of DJ-1 with
PBs, highly dynamic RNA granules which can exchange
components with SGs [11, 58]. Finally, we found that DJ-1
likely shifts from polysomes to SGs as a function of sorbitol
concentration, further supporting that DJ-1 is a bona fide SG
component. These data conclusively show for the first time, to
our knowledge, the association of DJ-1 with SGs in mamma-
lian cells, leading us to explore its functional relevance.
Notably, our results herein suggest that DJ-1 does not play a
role in size or number of SGs under the conditions tested. As
DJ-1 has previously been found to specifically bind a subset of
mRNAs [7, 8], we thus next asked whether DJ-1 targets a
subset of mRNAs to SGs. Supporting this hypothesis, we per-
formed ISH with GPx4, eIF4B, and eIF4EBP1 mRNAs as
candidate markers, and found an enrichment of these messages
co-localized to SGs in comparison to PBs, which served as
control RNA granules. These data—combined with past work
showing that DJ-1/mRNA interactions are abrogated under
oxidative stress conditions [7]—suggest that DJ-1 may play a
role in regulating translation of these messages during stress.
DJ-1 has recently been shown to deglycate methylglyoxal-
and glyoxal-glycated Cys, Arg, and Lys protein residues [59] as
well as methylglyoxal- and glyoxal-glycated nucleotides and
nucleic acids [60]. Strikingly, O-Glc-NAc glycosylation of pro-
teins enhances SG formation [61] and advanced glycation end
products induce SG assembly in human chondrocytes [62]. Our
recent work has highlighted the likely importance of glycation
in the pathogenesis of PD and Huntington’s disease [63, 64].
Thus, based upon these reports, it is possible that DJ-1
deglycates both proteins and nucleic acids within SGs.
We next explored DJ-1-associated SGs in models of neu-
rodegeneration. Employing a well-established model of
NMDA excitotoxicity in primary cortical neurons [50], we
observed redistribution of eIF3 and TIA1 proteins from the
cytoplasm to the neuropil of cortical neurons and formation of
SGs. As described for HEK 293T cells, DJ-1 co-localizes to
eIF3η-labeled SGs. Complementing these novel findings, the
presence of SGs directly correlated with NMDA-mediated
toxicity in the culture as determined by LDH (data not shown).
To our knowledge, this indicates for the first time that
overactivation of NMDA receptors affects RNA metabolism,
thus adding a new component to the complex picture of
excitotoxicty and related molecular pathways [46]. Similar
analyses with MPP+ and rotenone found that these neuro-
toxins promote the formation of DJ-1-associated SGs in do-
paminergic neuronal cultures at early timepoints (3 and 6 h),
which dissipate at longer treatment times (24 and 48 h).
Notably, the SG-containing cells in these dopaminergic neu-
ronal cultures lack TH-staining and present with low levels of
NURR1 expression. Since MPP+ is selectively taken up by
dopaminergic neurons [65], cells showing SG formation
might initially have expressed TH and Nurr1. This raises the
possibility that SG formation occurs either before or during
the decline of Nurr1 and TH expression, ultimately causing
neuronal death.While the functional relationship among these
observations is not clear, these novel insights suggest that DJ-
1-associated SGs may be mechanistically linked to the parkin-
sonian phenotypes generated by these toxins.
Taken together, our results suggest that DJ-1 may be in-
volved in the process of RNA triage in cells upon induction
of stress, which may be relevant to pathogenic mechanisms
underlying PD, and other neurodegenerative disorders which
exhibit DJ-1-related pathology. As DJ-1 has been linked to a
number of cellular processes, a role in RNA metabolism in
which specific mRNA populations are regulated by DJ-1 is
feasible. How, and if, such mechanisms contribute to disease
processes is unclear, but the link with PD-related toxins is
indicative. Nonetheless, it is now critical to follow on from
these studies by identifying and characterizing the mRNA pop-
ulations targeted by DJ-1 in the context of SG formation and
neurodegeneration, and understanding the downstream effects
of these interactions. Ultimately, such analyses will further
clarify how loss of DJ-1 function leads to PD, providing im-
portant insight into the molecular pathogenesis of this disorder.
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